Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-06-24 19:48:53
Reporting Period:
Accepted Time:
2020-06-24 19:48:53
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1448888 James William Kennedy 2 Gansevoort Street, 9Th Floor
New York NY 10014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-17 7,745 $18.27 94,633 No 4 S Direct
Common Stock Disposition 2020-06-22 15,000 $0.00 109,633 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
  1. In connection with the vesting of 15,000 shares on June 16, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Kennedy's tax obligations. Mr. Kennedy had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  2. Represents the weighted average sales price. The range of prices for such transaction was $18.20 to $18.36. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Includes shares of restricted Common Stock, which vest over various time periods.
  4. Reflects a grant of restricted shares that will vest on June 22, 2023.